Next Article in Journal
Gene Regulatory Effects of Sappan lignum Extract in a Cell Model of Joint Inflammation
Previous Article in Journal
Impact of Stabilizer Concentration on the Surface Functionalization of PLGA Particles
 
 
Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Microspheres Containing Carnosic Acid for the Treatment of Basil Fungal Diseases

1
Dipartimento di Chimica e Tecnologie Farmaceutiche e Alimentari, Università di Genova, Via Brigata Salerno 13, 16147 Genova, Italy
2
Centro Regionale di Sperimentazione e Assistenza Agricola, Camera di Commercio I.A.A. di Savona, Regione Rollo, 98, 17031 Albenga, Italy
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2009, 77(7), 236; https://doi.org/10.3797/scipharm.oephg.21.PO-37
Submission received: 16 April 2009 / Accepted: 16 April 2009 / Published: 16 April 2009

Abstract

Microspheres loaded with carnosic acid (CA) as an active ingredient which was extracted from various species of Salvia L., were prepared by a spray drying technology. The matrix of the microspheres consisted of 85% deacetylated chitosan (average MW 55000 kDa), poloxamer P407 and carnosic acid. Briefly, chitosan and poloxamer P407 were dissolved in 1% v/v acetic acid followed by dispersion of carnosic acid under vigorous stirring. The dispersion was then fed into a spray dryer (190 Mini, Büchi, Flawil, Switzerland) and processed under the following operative conditions: T inlet 180°C, T outlet 120°C, air aspiration 70% and peristaltic pump 15% (feeding rate 4 mL/min). This process yielded microspheres with 5-8 μm in diameter containing 17% active ingredients corresponding to an encapsulation efficiency of 45% and a practical yield of 34%.

Share and Cite

MDPI and ACS Style

RUSSO, E.; BISIO, A.; ROMUSSI, G.; PARODI, B.; CAVIGLIOLI, G.; MINUTO, G.; CAFAGGI, S. Microspheres Containing Carnosic Acid for the Treatment of Basil Fungal Diseases. Sci. Pharm. 2009, 77, 236. https://doi.org/10.3797/scipharm.oephg.21.PO-37

AMA Style

RUSSO E, BISIO A, ROMUSSI G, PARODI B, CAVIGLIOLI G, MINUTO G, CAFAGGI S. Microspheres Containing Carnosic Acid for the Treatment of Basil Fungal Diseases. Scientia Pharmaceutica. 2009; 77(Posters (PO)):236. https://doi.org/10.3797/scipharm.oephg.21.PO-37

Chicago/Turabian Style

RUSSO, E., A. BISIO, G. ROMUSSI, B. PARODI, G. CAVIGLIOLI, G. MINUTO, and S. CAFAGGI. 2009. "Microspheres Containing Carnosic Acid for the Treatment of Basil Fungal Diseases" Scientia Pharmaceutica 77, Posters (PO): 236. https://doi.org/10.3797/scipharm.oephg.21.PO-37

APA Style

RUSSO, E., BISIO, A., ROMUSSI, G., PARODI, B., CAVIGLIOLI, G., MINUTO, G., & CAFAGGI, S. (2009). Microspheres Containing Carnosic Acid for the Treatment of Basil Fungal Diseases. Scientia Pharmaceutica, 77(Posters (PO)), 236. https://doi.org/10.3797/scipharm.oephg.21.PO-37

Article Metrics

Back to TopTop